Skip to main content
Premium Trial:

Request an Annual Quote

William Janzen, Rudi Pauwels, Wilson Totten, David Stone

Premium
Amphora Discovery this week announced the appointment of William Janzen, a company co-founder, as president and chief operating officer.
 
Prior to his promotion, Janzen served as Amphora’s vice president of operations and chief technology officer. Prior to co-founding Amphora, Janzen spent 18 years in pharmaceutical R&D at Eli Lilly and Sphinx Pharmaceuticals.
 

 
Galapagos this week said it has added Rudi Pauwels as an independent, non-executive board member.
 
Pauwels is a co-founder of Galapagos, as well as Tibotec (now a part of Johnson & Johnson) and Virco.
 
Galapagos also said that Wilson Totten and David Stone stepped down as board members in December. Totten had served as a non-executive board member since Oct. 2004, while Stone had served since Galapagos’ Oct. 2005 acquisition of BioFocus.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.